I am grateful to those who identified my burnout and supported me to make changes and reverse the syndrome.
Pharmacists are in the perfect position to influence patients and improve outcomes with medication therapy management.
Among commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.
The FDA approved Edarbi (azilsartan medoxomil), a new angiotensin receptor blocker, for the treatment of hypertension in adults.
Advanced heart failure leads to significant limitations, affecting functional status, quality of life, and survival, despite optimal medical treatment with evidence-based therapies.
If you're not accredited with any of the major players, you could instantly lose out on future business growth opportunities.
A retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.
A telephonic pharmacist-delivered medication therapy management intervention is an effective method for increasing the utilization of guideline-recommended cardiovascular therapies in high-risk Medicare patients with diabetes.
Achieving a sustained viral response in patients with hepatitis C is showed to reduce the risk of liver cancer.
Perceived as the new “wonder drug,” immunoglobulin (IG) is a go-to therapy for healthcare providers seeking to bolster their patients’ immune systems; however, as demand grows, particularly for oncology and off-label indications, the supply can’t keep pace.
While warfarin remains the most commonly prescribed anticoagulant, novel anticoagulant use appears to be increasing especially among cardiologists. With new indications for these agents, uptake in prescribing by primary care providers is likely to increase.
Sarah Scoular, PharmD, BCPS, assistant professor at the University of Colorado Skaggs School of Pharmacy, discusses some of the international work she has been involved in.
Specialty pharmacy is beginning to implement its own set of strategies in order to manage the cost of one of the most expensive sectors of the pharmaceutical industry.
The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that general availability for the .pharmacy domain begins June 3, 2015.
In a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.
Among psoriasis patients initiated on oral nonbiologic or on biologic therapy, most patients undergo at least 1 therapy change within 4 months of treatment initiation.
The primary care physician for a 67-year-old female patient with hypertension, dyslipidemia, and chronic non-ischemic systolic heart failure wants to know whether to initiate an antithrombotic agent.
Complex distribution challenges for manufacturers of specialty drugs require life science and cold chain experts to provide a faster, better way of distributing these life-saving medications.
A unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.
Less than one-fourth of Part D beneficiaries reported switching plans. Elderly beneficiaries who reported switching did not realize significant savings in prescription costs over nonswitchers.
An estimation and comparison of the cost of home phototherapy versus biologics over a 3-year time horizon in patients with moderate-to-severe plaque psoriasis.
This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
Pharmacists can educate patients about how to recognize unsafe online sources of medications and ensure patients are properly educate on how to administer their medications.
As new biosimilars enter the market, pharmacies should carefully consider infrastructure, resources, and strategies for successfully integrating the products into their portfolio of offerings.
This case highlights the legal principle of premises liability